D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$354M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$309M |
| 3 |
Microsoft
MSFT
|
+$307M |
| 4 |
Automatic Data Processing
ADP
|
+$266M |
| 5 |
Citigroup
C
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$567M |
| 2 |
Fidelity National Information Services
FIS
|
+$410M |
| 3 |
Medtronic
MDT
|
+$359M |
| 4 |
Amazon
AMZN
|
+$297M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 12.73% |
| 3 | Healthcare | 11.62% |
| 4 | Financials | 8.02% |
| 5 | Industrials | 6.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRG
3301
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $371K | ﹤0.01% |
31,490
+11,565
| +58% | +$138K |
|
3302
Celanese
CE
$5.09B
| $369K | ﹤0.01% |
3,014
-86,892
| -97% | -$9.79M |
|
3303
PUT
Deckers Outdoor
DECK
$13.3B
| $368K | ﹤0.01% |
15,000
| – | – |
|
3304
LeMaitre Vascular
LMAT
$2.18B
| $367K | ﹤0.01% |
10,745
+2,838
| +36% | +$90.7K |
|
|
ADMS
3305
DELISTED
Adamas Pharmaceuticals
ADMS
| $367K | ﹤0.01% |
+71,724
| New | +$443K |
|
|
GHL
3306
DELISTED
Greenhill & Co., Inc.
GHL
| $365K | ﹤0.01% |
27,810
-4,213
| -13% | -$60.2K |
|
|
CCXI
3307
DELISTED
ChemoCentryx, Inc.
CCXI
| $363K | ﹤0.01% |
53,417
-39,793
| -43% | -$299K |
|
3308
CALL
Albemarle
ALB
$13.5B
| $362K | ﹤0.01% |
5,200
-1,700
| -25% | -$116K |
|
|
ARR
3309
Armour Residential REIT
ARR
$2.02B
| $362K | ﹤0.01% |
4,320
-2,704
| -38% | -$236K |
|
|
EB
3310
DELISTED
Eventbrite
EB
| $362K | ﹤0.01% |
20,445
-3,432
| -14% | -$60.2K |
|
|
BSTC
3311
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $362K | ﹤0.01% |
6,769
| – | – |
|
3312
Supernus Pharmaceuticals
SUPN
$2.68B
| $360K | ﹤0.01% |
+13,100
| New | +$388K |
|
3313
The Joint Corp
JYNT
$119M
| $359K | ﹤0.01% |
+19,291
| New | +$357K |
|
3314
Sonida Senior Living
SNDA
$1.97B
| $357K | ﹤0.01% |
5,427
-1,971
| -27% | -$138K |
|
|
TTM
3315
DELISTED
Tata Motors Limited
TTM
| $357K | ﹤0.01% |
42,538
-50,196
| -54% | -$475K |
|
|
ENDP
3316
DELISTED
Endo International plc
ENDP
| $357K | ﹤0.01% |
111,128
-540,129
| -83% | -$1.74M |
|
3317
Sierra Bancorp
BSRR
$548M
| $356K | ﹤0.01% |
13,406
-1,220
| -8% | -$31.4K |
|
|
3318
PUT
Automatic Data Processing
ADP
$100B
| $355K | ﹤0.01% |
2,200
| – | – |
|
3319
Fortuna Silver Mines
FSM
$2.59B
| $355K | ﹤0.01% |
114,799
-232,900
| -67% | -$850K |
|
3320
Lifecore Biomedical
LFCR
$162M
| $355K | ﹤0.01% |
+32,692
| New | +$356K |
|
3321
PTC
PTC
$13.7B
| $355K | ﹤0.01% |
+5,206
| New | +$380K |
|
|
SAFE
3322
DELISTED
Safehold Inc.
SAFE
| $355K | ﹤0.01% |
+11,632
| New | +$354K |
|
3323
Tandem Diabetes Care
TNDM
$1.17B
| $353K | ﹤0.01% |
+5,983
| New | +$382K |
|
3324
Smart Sand
SND
$200M
| $352K | ﹤0.01% |
124,467
+24,712
| +25% | +$61.7K |
|
3325
Precigen
PGEN
$1.93B
| $351K | ﹤0.01% |
61,237
+44,294
| +261% | +$301K |
|
Similar funds
D.E. Shaw & Co's Q3 2019 Portfolio in Review
As of Q3 2019, D.E. Shaw & Co held 4,189 positions worth $81.2B, up 1.3% from $80.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q3 2019 filing shows 550 new, 1,503 increased, 1,391 reduced and 422 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M. The largest sale was Anadarko Petroleum, an estimated $567M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M.
- D.E. Shaw & Co added most to PayPal in Q3 2019, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2019 reduction was Fidelity National Information Services, cutting an estimated $410M.
- D.E. Shaw & Co fully exited Anadarko Petroleum in Q3 2019, selling an estimated $567M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $81.2B portfolio in Q3 2019.
- D.E. Shaw & Co opened 550 new positions and closed 422 in Q3 2019.
- D.E. Shaw & Co's portfolio value rose 1.3% quarter-over-quarter to $81.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.